Search | DIAL.pr - BOREAL

Accès à distance ? S'identifier sur le proxy UCLouvain

Displaying 2 results.

- Journal article
Recombinant tissue factor pathway inhibitor in severe community-acquired pneumonia : a randomized trial.
Wunderink, Richard G. Laterre, Pierre-François[UCL] Francois, Bruno Perrotin, Dominique Artigas, Antonio Vidal, Luis Otero Lobo, Suzana M. Juan, Jorge San Hwang, Sung Chul Dugernier, Thierry LaRosa, Steven Wittebole, Xavier[UCL] Dhainaut, Jean-Francois Doig, Christopher Mendelson, Meryl H Zwingelstein, Christian Su, Guoqin Opal, Steven CAPTIVATE Trial Group Dive, Alain-Michel[UCL] (2011) American Journal of Respiratory and Critical Care Medicine — Vol. 183, no. 11, p. 1561-1568 (2011)
- Journal article
Efficacy and Safety of Tifacogin (Recombinant Tissue Factor Pathway Inhibitor) in Severe Sepsis: A Randomized Controlled Trial
OPTIMIST Trial Study Group Abraham, Edward Reinhart, Konrad Opal, Steven Demeyer, Ignace Doig, Christopher López Rodriguez, Angel Beale, Richard Svoboda, Petr Laterre, Pierre-François[UCL] Simon, Stuart Light, Bruce Spapen, Herbert Stone, Judy Seibert, Allan Peckelsen, Claus De Deyne, Cathy Postier, Russell Pettilä, Ville Sprung, Charles L. Artigas, Antonio Percell, Sandra R. Shu, Vincent Zwingelstein, Christian Tobias, Jeffrey Poole, Lona Stolzenbach, James C. Creasey, Abla A. (2003) JAMA : the journal of the American Medical Association — Vol. 290, no. 2, p. 238-247 (2003)